Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8386
Evaluation of Fludarabine Phosphate in Colorectal Carcinoma TEMPORARILY CLOSED: 8/17/84
Activated
01-19-1984
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8361
Treatment of Non-Hodgkin's Lymphoma of Intermediate and High Grade Malignancy with CHOP Chemotherapy and Systemic (TB vs. HB) Radiotherapy
Activated
01-03-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8371
Evaluation of Diamine (1,1-Cyclobutane-Dicarboxylato-(2)-0,0')-CSP-4-2)Platinum (CBDCA-NSC-241240) and Cis-Dichloro-Trans-Dihydroxy-Bis-(Isoprpylamine)-Platinum IV (CHIP-NSC-256927) for Patients with Advanced (M1) and Recurrent Squamous Cell Cancer of the Head and Neck
Activated
12-22-1983
Closed
09-27-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8378
Evaluation of Fludarabine Phosphate in Chronic Lympho- cytic Leukemia
Activated
12-05-1983
Closed
06-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8367
Combined Modality Treatment of Regional Non-Small Lung Cancer
Activated
12-01-1983
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8240
Evaluation of Spiorgermanium (NSC-192965) in the Treatment of Metastatic Malignant Melanoma
Activated
11-14-1983
Closed
05-31-1986
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-8366
Cell Kinetic Measurement In Stage I and Stage II Node Negative or Node Positive (Pathological Stage T1-3, NO-1, MO) Breast Cancer, A Natural History Study
Activated
11-14-1983
Closed
11-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8308
Combination Cis-Platinum and Dichloromethotrexate
Activated
10-18-1983
Closed
03-14-1986
Closed
Phase
SWOG Clinical Trial Number
SWOG-8233
Evaluation of Aziridinylbenzoquinone (AZQ) in Gastric Carcinoma
Activated
10-18-1983
Closed
12-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8235
Evaluation of Continuous Infusion Vinblastine in Gastric Carcinoma.
Activated
10-18-1983
Closed
02-01-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-8369
Combination Chemotherapy with Mitoxantrone, Cis-Platinum and MGBG for Refractory Lymphoma
Activated
10-18-1983
Closed
07-15-1986
Closed
Phase
SWOG Clinical Trial Number
SWOG-8374
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8370
Vinblastine and Cis-Platinum in the Treatment of Refractory Sarcomas
Research Committee(s)
Sarcoma
Activated
07-26-1983
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8302
Study of Doxorubicin, Mitomycin-C and 5-Fluorouracil in the Treatment of Metastatic Adenocarcinoma of the Prostate
Activated
07-26-1983
Closed
08-17-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8311
Combination Chemotherapy with Cis-Platinum, Vinblastineand Methyglyoxal Bis (Guanylhydrazone)(MGBG) in Epidermoid Carcinoma of the Esophagus
Activated
07-26-1983
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8304
Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast
Activated
05-27-1983
Closed
05-04-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8305
Chemotherapy of Metastatic Colorectal Carcinoma with 5-FU and Folinic Acid
Activated
05-27-1983
Closed
03-16-1984
Closed
Phase
SWOG Clinical Trial Number
SWOG-8242
Evaluation of Estrogen-Antagonist in the Management of Pancreatic Carcinoma
Activated
05-27-1983
Closed
03-16-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8237
Evaluation of Continuous Infusion Vinblastine Sulfate in Pancreatic Adenocarcinoma
Activated
05-27-1983
Closed
03-22-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8364
Phase II Pilot Study of Immediate Post-Operative Adjuvant Chemotherapy in Patients with Operable Breast Cancer
Activated
05-27-1983
Closed
09-27-1985